With box warnings

Without box warnings

Branded

Generic

2 results

dexrazoxane
(Dexrazoxane for Injection)
Almaject, Inc.
Usage: Dexrazoxane for Injection is indicated to reduce cardiomyopathy incidence and severity in women with metastatic breast cancer receiving doxorubicin, after a cumulative dose of 300 mg/m², who will continue doxorubicin therapy for tumor control. It should not be used at the start of doxorubicin treatment.
dexrazoxane
(Dexrazoxane for Injection)
Almaject, Inc.
Usage: Dexrazoxane for Injection is indicated to reduce the incidence and severity of cardiomyopathy in women with metastatic breast cancer receiving cumulative doxorubicin doses of 300 mg/m² or more, who will continue doxorubicin therapy for tumor control. It should not be used at the start of doxorubicin therapy.

Cytoprotective Agent class drugs

dexrazoxane